Distinct modulation of chemokine expression patterns in human monocyte-derived dendritic cells by prostaglandin E2

被引:17
|
作者
Bruckner, Markus [1 ]
Dickel, Denise [1 ]
Singer, Eva [2 ]
Legler, Daniel F. [1 ]
机构
[1] Univ Konstanz, Biotechnol Inst Thurgau BITg, CH-8280 Kreuzlingen, Switzerland
[2] Klinikum Konstanz, Constance, Germany
基金
瑞士国家科学基金会;
关键词
Human monocyte-derived dendritic cells; Chemokines; Prostaglandin E-2; REGULATORY T-CELLS; TH17; CELLS; INFLAMMATORY CHEMOKINES; RECEPTOR EXPRESSION; IMMUNE-RESPONSES; CUTTING EDGE; KEY FACTOR; IN-VITRO; MATURATION; MIGRATION;
D O I
10.1016/j.cellimm.2012.03.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dendritic cells (DCs) are key in regulating immune responses. DCs reside in tissues facing the environment and sample their surrounding for pathogens. Upon pathogen encounter, DCs mature and migrate into secondary lymphoid organs. Distinct maturation signals dictate the ability of DCs to produce distinct patterns of chemokines that orchestrate immunity. Prostaglandin E-2 (PGE(2)) is produced during inflammation and modulates DC functions. We demonstrate that PGE(2) modulates distinct chemokine expression patterns of human monocyte-derived (Mo) DCs upon maturation with various stimuli. PGE(2) dampened early production of the inflammatory chemokines CCL2, CCL4, CCL5 and attenuated the expression of the T cell attractant CXCL10. In contrast, PGE(2) enhanced CXCL8 production early during maturation, whereas CXCL16 levels were continuously elevated, contributing to innate immune cell recruitment. Moreover, PGE(2) induces transcription of the homeostatic chemokines CCL17 and CCL22. Finally, mature MoDCs produced the homing chemokine CCL19 and its expression was down-regulated by PGE(2). (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 50 条
  • [41] Effect of piceatannol in human monocyte-derived dendritic cells in vitro
    Takei, M
    Umeyama, A
    Arihara, S
    Matsumoto, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (05) : 974 - 982
  • [42] Response of human monocyte-derived dendritic cells to immunostimulatory DNA
    Schattenberg, D
    Schott, M
    Reindl, G
    Krueger, T
    Tschoepe, D
    Feldkamp, J
    Scherbaum, WA
    Seissler, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (10) : 2824 - 2831
  • [43] Human in vivo-differentiated monocyte-derived dendritic cells
    Tang-Huau, Tsing-Lee
    Segura, Elodie
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2019, 86 : 44 - 49
  • [44] Cantharidin modulates development of human monocyte-derived dendritic cells
    Hsieh, Chen-Hsi
    Huang, Yu-Chuen
    Tsai, Tung-Hu
    Chen, Yu-Jen
    TOXICOLOGY IN VITRO, 2011, 25 (08) : 1740 - 1747
  • [45] Evaluation of phagocytic activity in human monocyte-derived dendritic cells
    Kiama, SG
    Cochand, L
    Karlsson, L
    Nicod, LP
    Gehr, P
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (03): : 289 - 299
  • [46] Polyacetylenediols regulate the function of human monocyte-derived dendritic cells
    Takei, Masao
    Umeyama, Akemi
    Shoji, Noboru
    Hashimoto, Toshihiro
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (08) : 913 - 921
  • [47] The effect of β-catenin inhibitors on human monocyte-derived dendritic cells
    Bakke, R. M.
    Oyan, A. M.
    Appel, S.
    Kalland, K. H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 83 - 83
  • [48] Nucleofection of a DNA vaccine into human monocyte-derived dendritic cells
    Xie, Qiu
    Luo, Jia
    Zhu, Zhiqiang
    Wang, Guoliang
    Wang, Jianhua
    Niu, Bo
    CELLULAR IMMUNOLOGY, 2012, 276 (1-2) : 135 - 143
  • [49] Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells
    Son, Yonsu
    Ito, Tomoki
    Ozaki, Yoshio
    Tanijiri, Tsutomu
    Yokoi, Takashi
    Nakamura, Kengo
    Takebayashi, Masashi
    Amakawa, Ryuichi
    Fukuhara, Shirou
    IMMUNOLOGY, 2006, 119 (01) : 36 - 42
  • [50] Distinct mechanisms are involved in tumoristatic and tumoricidal activities of monocyte-derived dendritic cells
    Vanderheyde, N
    Vandenabeele, P
    Goldman, M
    Willems, F
    IMMUNOLOGY LETTERS, 2004, 91 (2-3) : 99 - 101